Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Inventory (2016 - 2025)

Apyx Medical's Inventory history spans 16 years, with the latest figure at $9.8 million for Q4 2025.

  • For Q4 2025, Inventory rose 29.68% year-over-year to $9.8 million; the TTM value through Dec 2025 reached $9.8 million, up 29.68%, while the annual FY2025 figure was $9.8 million, 29.68% up from the prior year.
  • Inventory reached $9.8 million in Q4 2025 per APYX's latest filing, down from $10.3 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $12.0 million in Q3 2022 to a low of $4.5 million in Q1 2021.
  • Average Inventory over 5 years is $9.0 million, with a median of $9.5 million recorded in 2022.
  • Peak YoY movement for Inventory: decreased 24.0% in 2021, then surged 99.37% in 2022.
  • A 5-year view of Inventory shows it stood at $6.8 million in 2021, then skyrocketed by 74.05% to $11.8 million in 2022, then dropped by 15.89% to $9.9 million in 2023, then decreased by 23.77% to $7.6 million in 2024, then grew by 29.68% to $9.8 million in 2025.
  • Per Business Quant, the three most recent readings for APYX's Inventory are $9.8 million (Q4 2025), $10.3 million (Q3 2025), and $9.3 million (Q2 2025).